PRESS RELEASE People should be more involved in decisions about their medicines to ensure best outcomes from them. New guideline on medicine optimisation published today outlines that having people at the centre of decisions about their care may enable them to use their prescribed medicines safely and effectively so getting the best possible outcomes from…
uk: Ensuring best care for older people living at home
Ensuring best care for older people living at home Draft guideline to help home care services provide highest level of supports to older people living at home. In 2011, 1 in 6 people in England and Wales were aged 65 or over. and expected to grow to about 1 in 4 by 2035. UK society…
EU:Commission to fight poverty and help most vulnerable
Commission commits €3.8 billion to fight poverty in Europe The Commission finalised the process of adoption of all national Operational Programmes implementing funding for European Aid worth 3.8 billion euro in non-financial assistance to those most in need. FEAD gives Member States valuable support in efforts to help Europe’s most vulnerable,those worst affected by the…
Expert Workshops: Sex and Gender in Medicine Regulation, Medical Education
EVENT Expert Workshops on Sex and Gender in Medicines Regulation and Medical Education 4th March 2015, 0900-1730. Room TRE7701, 7th floor, Trèves Building, 74 Rue de Trèves. European Economic and Social Committee, Brussels Research addressing Sex and Gender (S&G) in biomedical science and health research is a novel and highly promising field. The interaction of…
UK: Treatment guides for treating kidney and prostate cancer
Final guidance on use of axitinib for treating kidney cancer and sipuleucel-T for prostate cancer. Guidance issued to the NHS today, recommends that the drug axitinib, known as Inlyta by Pfizer, should be available as a second line treatment for kidney cancer. A separate new guide did not recommended sipuleucel-T, known as Provenge, for treating…
Europe: Sexually transmitted infections 2014 report
Sexually transmitted infections, including HIV and blood-borne viruses Annual report with overview of the epidemiology of diseases based on 2012 data: Chlamydia Chlamydia is the most frequently reported sexually transmitted infection (STI) in the European Union and European Economic Area (EU/EEA). In 2012, 384 105 cases of chlamydia were reported in 25 EU/EEA Member States.…
Association of exposure to pesticides and health outcomes
Association between exposure to pesticides and health outcomes 2006 – 2012 In 2013, EFSA published a report on a systematic review of studies published between 2006 and 2012 which showed a statistically significant association between exposure to pesticides and health outcomes such as liver cancer, breast cancer, type II diabetes, childhood leukaemia and Parkinson’s disease.…
Report on consumption of antimicrobial agents
ECDC/EFSA/EMA first joint report The ECDC/EFSA/EMA published the first joint report on an integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals. The report will inform the European Commission’s action plan against the rising threats from antimicrobial resistance and the data from the report…
Improving patient safety: fighting antimicrobial resistance
Safer healthcare in Europe: improving patient safety and fighting antimicrobial resistance Consideration of draft report Council Recommendation of 9 June 2009 (2009/C 151/01) on patient safety, including the prevention and control of healthcare associated infections called for the implementation of a series of measures to improve patient safety in the EU. The Commission published in…
IE: Public consultation on easier access to ‘rescue’ drugs
Ireland: Public consultation on easier access to ‘rescue’ drugs in emergencies Varadkar: public consultation on easier access to ‘rescue’ drugs in emergencies To include epipens, Adrenaline, salbutamol, glucagon, naloxone and glyceryl trinitrate Minister for Health Leo Varadkar has launched a consultation process on whether to make a number of prescription-only medicines used in emergency situations…